Autophagy inhibition synergistically enhances anti-cancer efficacy of RAMBA, VN/12-1 in SKBR-3 cells and tumor xenografts

Documenti analoghi

• Murine toxicology and pharmacokinetics evaluation of Retinoic Acid Metabolism Blocking Agent (RAMBA), VN/12-1
  di: Godbole, Abhijit M., et al.
  Pubblicazione: (2012)
• Synthesis and biological evaluations of putative metabolically stable analogs of VN/124-1 (TOK-001) analogs: Head to head anti-tumor efficacy evaluation of VN/124-1 (TOK-001) and abiraterone in LAPC-4 human prostate cancer xenograft model
  di: Bruno, Robert D., et al.
  Pubblicazione: (2011)
• First Chemical Feature Based Pharmacophore Modeling of Potent Retinoidal Retinoic Acid Metabolism Blocking Agents (RAMBAs): Identification of Novel RAMBA Scaffolds
  di: Purushottamachar, Puranik, et al.
  Pubblicazione: (2011)
• Improved Synthesis of Histone Deacetylase Inhibitors (HDIs) (MS-275 and CI-994) and Inhibitory Effects of HDIs Alone or in Combination with RAMBAs or Retinoids on Growth of Human LNCaP Prostate Cancer Cells and Tumor Xenografts
  di: Gediya, Lalji, et al.
  Pubblicazione: (2007)
• MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours
  di: Khandelwal, A, et al.
  Pubblicazione: (2008)